‘Based on the World Heart Association, 17.1 million people die each full year from cardiovascular disease, 80 % of whom are in developing countries. These sobering numbers highlight the importance of not only conducting further research into coronary disease but also making sure this research is carried out globally.’.. ACRO releases declaration on World Heart Day The Association of Clinical Analysis Institutions , which represents the global leaders in clinical outsourcing, today released the following statement in recognition of Globe Heart Day. ‘Last year, ACRO member companies conducted nearly 600 clinical trials of brand-new drugs and treatments for cardiovascular disease involving 230, 000 sufferers around the global globe,’ stated Doug Peddicord, PhD, Executive Director.We are acquiring great strides through these applications, but more can be achieved and we motivate the development and growth of similar programs through the entire country.’ ‘Survivorship applications allow us to examine, monitor and conduct research on AYAs and other childhood cancer patients in remission, and several pediatric hematology/oncology nurses right now work in these programs. Through these applications we are increasing tumor patients’ chances of survival. However, most survivorship programs are within their infancy and are largely underfunded still.